Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
Midway Immunology and Research Center
mi
from
Fort Pierce, FL
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
Midway Immunology and Research Center
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
Orlando Immunology Center
mi
from
Orlando, FL
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
Orlando Immunology Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
IDOCF/ValueHealthMD, LLC
mi
from
Orlando, FL
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
IDOCF/ValueHealthMD, LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
Infectious Disease Specialists of Atlanta
mi
from
Decatur, GA
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
Infectious Disease Specialists of Atlanta
mi
from
Decatur, GA
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
Mercer University/ Mercer Medicine Clinical Research
mi
from
Macon, GA
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
Mercer University/ Mercer Medicine Clinical Research
mi
from
Macon, GA
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
Northstar Medical Center
mi
from
Chicago, IL
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
Northstar Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
The Research Institute
mi
from
Springfield, MA
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
The Research Institute
mi
from
Springfield, MA
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
Be Well Medical Center
mi
from
Berkley, MI
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
Be Well Medical Center
mi
from
Berkley, MI
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
Central West Clinical Research, Inc.
mi
from
St. Louis, MO
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
Central West Clinical Research, Inc.
mi
from
St. Louis, MO
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
ID Care, Inc.
mi
from
Hillsborough, NJ
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
ID Care, Inc.
mi
from
Hillsborough, NJ
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
North Shore University Hospital
mi
from
Manhasset, NY
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
Chelsea Village Medical
mi
from
New York, NY
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
Chelsea Village Medical
mi
from
New York, NY
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
Mount Sinai Downtown Comprehensive Health Program
mi
from
New York, NY
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
Mount Sinai Downtown Comprehensive Health Program
mi
from
New York, NY
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
AIDS Care
mi
from
Rochester, NY
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
AIDS Care
mi
from
Rochester, NY
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
Carolinas Medical Center
mi
from
Charlotte, NC
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
Southwest Infectious Disease Clinical Research, Inc.
mi
from
Addison, TX
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
Southwest Infectious Disease Clinical Research, Inc.
mi
from
Addison, TX
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
Tarrant County Infectious Disease Associates
mi
from
Fort Worth, TX
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
Tarrant County Infectious Disease Associates
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  3/23/2012
Therapeutic Concepts, P.A.
mi
from
Houston, TX
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 3/23/2012
Therapeutic Concepts, P.A.
mi
from
Houston, TX
Click here to add this to my saved trials
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
Status: Enrolling
Updated:  4/9/2012
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
Status: Enrolling
Updated: 4/9/2012
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Effects of Short-term Growth Hormone in HIV-infected Patients
Effects of Short-term Growth Hormone in HIV-infected Patients
Status: Enrolling
Updated:  4/18/2012
MGH
mi
from
Boston, MA
Effects of Short-term Growth Hormone in HIV-infected Patients
Effects of Short-term Growth Hormone in HIV-infected Patients
Status: Enrolling
Updated: 4/18/2012
MGH
mi
from
Boston, MA
Click here to add this to my saved trials
A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV
Phase III, Placebo-Controlled, Double-Blind Crossover Study of Slow-Release Methylphenidate (Concerta ™) for Treatment of HIV Associated Neurocognitive Disorder
Status: Enrolling
Updated:  5/14/2012
UCLA CARE Clinic
mi
from
Los Angeles, CA
A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV
Phase III, Placebo-Controlled, Double-Blind Crossover Study of Slow-Release Methylphenidate (Concerta ™) for Treatment of HIV Associated Neurocognitive Disorder
Status: Enrolling
Updated: 5/14/2012
UCLA CARE Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine
Uridine Supplementation, Mitochondrial Function, and Glucose Metabolism in HIV
Status: Enrolling
Updated:  5/15/2012
University of California at San Francisco
mi
from
San Francisco, CA
Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine
Uridine Supplementation, Mitochondrial Function, and Glucose Metabolism in HIV
Status: Enrolling
Updated: 5/15/2012
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Pilot Study of Raltegravir Lipodystrophy IISP
Pilot Study on the Efficacy of a Two Drug, Raltegravir-based Regimen,(NRTI) Sparing Antiretroviral Treatment
Status: Enrolling
Updated:  5/16/2012
VA Long Beach Healthcare System
mi
from
Long Beach, CA
Pilot Study of Raltegravir Lipodystrophy IISP
Pilot Study on the Efficacy of a Two Drug, Raltegravir-based Regimen,(NRTI) Sparing Antiretroviral Treatment
Status: Enrolling
Updated: 5/16/2012
VA Long Beach Healthcare System
mi
from
Long Beach, CA
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Alabama Therapeutics CRS (5801)
mi
from
Birmingham, AL
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Alabama Therapeutics CRS (5801)
mi
from
Birmingham, AL
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
UCLA CARE Center CRS (601)
mi
from
Los Angeles, CA
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
UCLA CARE Center CRS (601)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
University of Southern California CRS (1201)
mi
from
Los Angeles, CA
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
University of Southern California CRS (1201)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Stanford
mi
from
Stanford, CA
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Stanford
mi
from
Stanford, CA
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Ucsd, Avrc Crs (701)
mi
from
San Diego, CA
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Ucsd, Avrc Crs (701)
mi
from
San Diego, CA
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
University of California San Francisco AIDS CRS (801)
mi
from
San Francisco, CA
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
University of California San Francisco AIDS CRS (801)
mi
from
San Francisco, CA
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
University of Miami AIDS CRS (901)
mi
from
Miami, FL
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
University of Miami AIDS CRS (901)
mi
from
Miami, FL
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
The Ponce de Leon Ctr. CRS (5802)
mi
from
Atlanta, GA
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
The Ponce de Leon Ctr. CRS (5802)
mi
from
Atlanta, GA
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Rush University Medical Center (2702)
mi
from
Chicago, IL
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Rush University Medical Center (2702)
mi
from
Chicago, IL
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Northwestern University CRS (2701)
mi
from
Chicago, IL
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Northwestern University CRS (2701)
mi
from
Chicago, IL
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
IHV Baltimore Treatment CRS (4651)
mi
from
Baltimore, MD
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
IHV Baltimore Treatment CRS (4651)
mi
from
Baltimore, MD
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Beth Israel Deaconess Medical Center ACTG CRS (103)
mi
from
Boston, MD
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Beth Israel Deaconess Medical Center ACTG CRS (103)
mi
from
Boston, MD
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Massachusetts General Hospital ACTG CRS (101)
mi
from
Boston, MA
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Massachusetts General Hospital ACTG CRS (101)
mi
from
Boston, MA
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Henry Ford Hosp. CRS (31472)
mi
from
Detroit, MI
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Henry Ford Hosp. CRS (31472)
mi
from
Detroit, MI
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Washington University CRS (2101)
mi
from
St. Louis, MO
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Washington University CRS (2101)
mi
from
St. Louis, MO
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Cooper Univ. Hosp. CRS (31476)
mi
from
Camden, NJ
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Cooper Univ. Hosp. CRS (31476)
mi
from
Camden, NJ
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
New Jersey Medical School- Adult Clinical Research Ctr. CRS
mi
from
Newark, NJ
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
New Jersey Medical School- Adult Clinical Research Ctr. CRS
mi
from
Newark, NJ
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Cornell CRS (7804)
mi
from
New York, NY
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Cornell CRS (7804)
mi
from
New York, NY
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
HIV Prevention and Treatment
mi
from
New York, NY
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
HIV Prevention and Treatment
mi
from
New York, NY
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
University of Rochester ACTG CRS (1101)
mi
from
Rochester, NY
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
University of Rochester ACTG CRS (1101)
mi
from
Rochester, NY
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
AIDS Care CRS (1108)
mi
from
Rochester, NY
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
AIDS Care CRS (1108)
mi
from
Rochester, NY
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
University of North Carolina AIDS CRS
mi
from
Chapel Hill, NC
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
University of North Carolina AIDS CRS
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Duke Univ. Med. Ctr. Adult CRS (1601)
mi
from
Durham, NC
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Duke Univ. Med. Ctr. Adult CRS (1601)
mi
from
Durham, NC
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Moses H. Cone Memorial Hosp. CRS
mi
from
Greensboro, NC
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Moses H. Cone Memorial Hosp. CRS
mi
from
Greensboro, NC
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Univ. of Cincinnati CRS
mi
from
Cincinnati, OH
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Univ. of Cincinnati CRS
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
MetroHealth CRS (2503)
mi
from
Cleveland, OH
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
MetroHealth CRS (2503)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated:  5/30/2012
Case CRS (2501)
mi
from
Cleveland, OH
Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
Status: Enrolling
Updated: 5/30/2012
Case CRS (2501)
mi
from
Cleveland, OH
Click here to add this to my saved trials